Medicare, Reversing Itself, Will Pay More for an Expensive New Cancer Drug

New York TimesMedicare, Reversing Itself, Will Pay More for an Expensive New Cancer DrugNew York TimesWASHINGTON — The Obama administration has decided that Medicare will pay for one of the newest, most expensive cancer medications, which costs about $178,000 for a standard course of treatment. Patients, doctors, hospital executives and insurers ...and more »

Share this post